Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glargine insulin for perioperative glycemic control in type 2 diabetes during on-pump CABG
IRCT20130428013159N12Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Aug 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in type 2 diabetes mellitus (T2DM) comparing Glargine insulin + regular insulin with Dextrose 5% control + regular insulin (2 arms). Primary endpoints: Blood glucose, ICU length of stay and 2 more. Started Aug 2020; status: completed.
02
Drugs
insulin glarginehuman insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT20130428013159N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130428013159N12.